Magali Roche

569 total citations
8 papers, 432 citations indexed

About

Magali Roche is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Magali Roche has authored 8 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Epidemiology. Recurrent topics in Magali Roche's work include MicroRNA in disease regulation (3 papers), interferon and immune responses (2 papers) and Cancer-related molecular mechanisms research (2 papers). Magali Roche is often cited by papers focused on MicroRNA in disease regulation (3 papers), interferon and immune responses (2 papers) and Cancer-related molecular mechanisms research (2 papers). Magali Roche collaborates with scholars based in France, Italy and Egypt. Magali Roche's co-authors include Anne Wierinckx, Jacqueline Trouillas, Catherine Legras‐Lachuer, Gérald Raverot, Joël Lachuer, Alfredo Fusco, Dario Palmieri, Monica Fedele, Carlo M. Croce and Paula Müssnich and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Hepatology and Frontiers in Immunology.

In The Last Decade

Magali Roche

8 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Magali Roche France 8 174 149 122 98 87 8 432
Luisa Ronzoni Italy 13 188 1.1× 27 0.2× 23 0.2× 29 0.3× 86 1.0× 43 455
Christine M. Matullo United States 7 277 1.6× 21 0.1× 44 0.4× 175 1.8× 99 1.1× 8 566
Neziha Cengic Germany 9 136 0.8× 84 0.6× 44 0.4× 58 0.6× 73 0.8× 9 391
Adi Egozi Israel 7 245 1.4× 48 0.3× 45 0.4× 80 0.8× 84 1.0× 13 475
Genglin Zhang China 12 139 0.8× 9 0.1× 50 0.4× 131 1.3× 156 1.8× 30 368
Charline Ladroue France 3 231 1.3× 91 0.6× 207 1.7× 3 0.0× 23 0.3× 4 441
Piyush Sharma Germany 9 93 0.5× 16 0.1× 47 0.4× 38 0.4× 52 0.6× 15 408
Xingang Zhou China 10 141 0.8× 10 0.1× 61 0.5× 37 0.4× 96 1.1× 39 313
David L. Armistead United States 4 276 1.6× 10 0.1× 263 2.2× 26 0.3× 72 0.8× 6 431

Countries citing papers authored by Magali Roche

Since Specialization
Citations

This map shows the geographic impact of Magali Roche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magali Roche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magali Roche more than expected).

Fields of papers citing papers by Magali Roche

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magali Roche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magali Roche. The network helps show where Magali Roche may publish in the future.

Co-authorship network of co-authors of Magali Roche

This figure shows the co-authorship network connecting the top 25 collaborators of Magali Roche. A scholar is included among the top collaborators of Magali Roche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magali Roche. Magali Roche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Pizzorno, Andrés, Olivier Terrier, Thomas Julien, et al.. (2019). Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures. Frontiers in Immunology. 10. 60–60. 44 indexed citations
2.
Roche, Magali, et al.. (2018). Massively parallel and multiplex blood group genotyping using next-generation-sequencing. Clinical Biochemistry. 60. 71–76. 9 indexed citations
3.
Bouzid, Amal, Ibtihel Smeti, Magali Roche, et al.. (2018). Down-expression of P2RX2, KCNQ5, ERBB3 and SOCS3 through DNA hypermethylation in elderly women with presbycusis. Biomarkers. 23(4). 347–356. 33 indexed citations
4.
Wierinckx, Anne, Magali Roche, Catherine Legras‐Lachuer, et al.. (2017). MicroRNAs in pituitary tumors. Molecular and Cellular Endocrinology. 456. 51–61. 37 indexed citations
5.
Debing, Yannick, Christophe Ramière, Kai Dallmeier, et al.. (2016). Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivity. Journal of Hepatology. 65(3). 499–508. 102 indexed citations
6.
Roche, Magali, Anne Wierinckx, Séverine Croze, et al.. (2015). Deregulation of miR-183 and KIAA0101 in Aggressive and Malignant Pituitary Tumors. Frontiers in Medicine. 2. 54–54. 35 indexed citations
7.
D’Angelo, Daniela, Dario Palmieri, Paula Müssnich, et al.. (2012). Altered MicroRNA Expression Profile in Human Pituitary GH Adenomas: Down-Regulation of miRNA Targeting HMGA1, HMGA2, and E2F1. The Journal of Clinical Endocrinology & Metabolism. 97(7). E1128–E1138. 123 indexed citations
8.
Wierinckx, Anne, Magali Roche, Gérald Raverot, et al.. (2011). Integrated Genomic Profiling Identifies Loss of Chromosome 11p Impacting Transcriptomic Activity in Aggressive Pituitary PRL Tumors. Brain Pathology. 21(5). 533–543. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026